LAB fluidigm.com Expected net earnings per share growth this year

LAB (Standard BioTools Corp) - company brandmark

Standard BioTools Inc. supplies genetics equipment, ensuring a stable revenue stream through recurring sales of consumables. The updated management is effectively consolidating bioanalytical platforms in a drive toward profitability. However, low customer capital expenditures and asset integration costs create risks. The annual earnings per share growth metric on GURU.Markets contains 33.30, recorded as the baseline value.

Standard BioTools (LAB) - Earnings growth in current year from 04/28/2023 to 11/10/2026

Financial and market metric breakdowns for Standard BioTools Inc. (LAB)

- current quotes and average value forecast:
Fundamental valuation:Standard BioTools Inc.
Brand item of Standard BioTools Inc

This indicator measures the dynamics of net earnings per share as a percentage relative to the same period last year, allowing for an assessment of real capital generation efficiency. By analyzing the proportional growth of EPS compared to last year, an investor can see how the monetization of Standard BioTools (LAB) microfluidic technologies in the field of high-precision bioanalysis transforms into a concrete increase in shareholder value.

Main competitors

A - Expected net earnings per share growth this year|Earnings per share growth in current year Quest|Illumina Platform (ILMN) - Expected net earnings per share growth this year|Net earnings per share growth this year EXAS (Exact Sciences)|Net earnings per one share growth for the current year RVTY|Earnings growth in current year BIO (Bio-Rad)|Earnings growth in current year Anbio Biotechnology Ltd NNNN|SHC - Earnings per share growth in current year|QDEL (QuidelOrtho Inc.) - Earnings per share growth this year|OPK: Earnings growth in current year|Earnings per share growth this year CDNA|MRVI (Maravai LifeSciences Holdings, Inc.) - Earnings growth in current year|Earnings growth in current year Fulgent Genetics Inc|Earnings per share growth in current year Cytek Bio (CTKB)|OSUR (OraSure Corp) - Earnings per share increase in current year|Earnings growth in current year XGN (Exagen)|MDXH: Earnings per share growth this year|LUCD: Net earnings per share growth this year|Earnings per share increase in current year PRE (Prenetics Global)|IMDX: Earnings growth in current year|TRIB (Trinity Biotech) - Earnings per share growth in current year|PRPH (ProPhase Labs, Inc.) - Earnings growth in current year|ainos.com (AIMD) - Expected net earnings per share growth this year|Earnings per share growth in current year Co-Diagnostics (CODX)|HSCS - Earnings per share growth rate in current year|Biomerica, Inc - Net earnings per share growth this year|Net earnings per one share growth for the current year CDIO (Cardio Diagnostics Holdings Inc.)|ONCO - Earnings per share growth in current year|Earnings per share growth rate in current year viraxbiolabs.com|Bluejay Diagnostics, Inc. (BJDX) - Earnings per share growth in current year|Earnings per share growth rate in current year Aspira Women's Health, Inc. (AWH)|Earnings per share growth in current year Accelerate Diagnostics, Inc|Earnings per share growth in current year CNTG|Earnings per share growth in current year Enzo Biochem, Inc. (ENZ)|Expected net earnings per share growth this year fresh2.co|Genetic Technologies Limited - Net earnings per share growth this year|Earnings per share increase in current year ME|Psychemedics Corp - Earnings growth in current year